NGL Fine-Chem Ltd. (NGLFINE) Share Price Trades Within 2% of 52-Week High
- August 10, 2026
- Posted by: Harsh Piplani
- Category: News
NGL Fine-Chem Ltd. Share Price stood at Rs 3,487.80 at qualification time, with the stock trading within 2% of its 52-week high and a market capitalisation of Rs 2,118.60 crore.
NGL Fine-Chem Ltd. Share Price was at Rs 3,487.80 when the Univest screener identified the stock on 10 August 2026 at 10:30:37 AM IST as trading within 2% of its 52-week high. The company’s market capitalisation stood at Rs 2,118.60 crore, placing it in the mid-sized band of listed pharmaceutical names tracked in the same industry set.
This matters because proximity to a one-year peak often brings a stock back onto investor watchlists, especially when valuation and profitability numbers are already strong enough to support attention. In this case, the verified data confirms the price event and also shows that NGL Fine-Chem Ltd. Share Price is being supported by return ratios that are well above same-industry medians, even as the stock trades at richer valuation multiples than many peers.
For readers tracking NGL Fine-Chem Ltd. Share Price Today, the current setup is less about a claimed catalyst and more about the combination of price strength, a Rs 2,118.60 crore market value, a P/E of 44.02 and healthy profitability metrics. That makes this a useful stock analysis case for monitoring through Univest, especially in the Healthcare sector and Pharmaceuticals & Drugs industry.
NGL Fine-Chem Ltd. Share Price Today: Within 2% of 52-Week High
| Metric | Value |
|---|---|
| LTP at 2% Qualification | Rs 3,487.8 |
| Market Capitalisation | Rs 2,118.6 crore |
| 52-Week High Position | Trading within 2% of its 52-week high |
NGL Fine-Chem Ltd. (NGLFINE) traded at Rs 3,487.8. Reported volume was 191.
NGL Fine-Chem Ltd. Share Price Today is Rs 3,487.80 based on the event-time last traded price captured by Univest. The same screener event identifies the stock as trading within 2% of its 52-week high, which is enough on its own to place the counter in a high-attention category for traders and investors who track relative strength and yearly price levels.
Because the stock is close to its one-year high, market participants typically start asking whether the move is being accompanied by strong financial quality, demanding valuation, or peer outperformance. The supplied data confirms the proximity event, but it does not establish a company-specific catalyst. Even so, NGL Fine-Chem Ltd. Share Price tends to attract additional scrutiny when it is within striking distance of a yearly peak because that zone often reflects sustained market interest rather than a random price swing.
Another reason this setup is notable is that NGL Fine-Chem Ltd. Share Price is being viewed in the context of a Rs 2,118.60 crore market capitalisation and a pharmaceuticals industry peer set where size, profitability and valuation can differ sharply. A stock nearing its 52-week high can invite momentum-focused attention, but the more important question is whether the numbers underneath the move justify continued tracking. That is why the next step is to look beyond the headline price event and assess the company’s fundamentals, sector standing and peer metrics through the lens of verified Univest data.
NGL Fine-Chem Ltd. (NGLFINE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,118.6 crore |
| P/E Ratio | 44.02x |
| P/B Ratio | 6.43x |
| ROE | 27.9% |
| ROCE | 33.91% |
| EPS | Rs 77.9 |
| Book Value Per Share | Rs 532.92 |
| Dividend Yield | 0.05% |
NGL Fine-Chem Ltd. was valued at a P/E ratio of 44.02x, a P/B ratio of 6.43x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 27.9% and ROCE of 33.91%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 77.9, book value per share of Rs 532.92, dividend yield of 0.05%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 44.02x |
| Benchmark Median P/E | 18.11x |
| Benchmark Average P/E | 60.11x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 6.43x |
| Benchmark Median P/B | 1.82x |
| Company ROE | 27.9% |
| Benchmark Median ROE | 9.89% |
| Company ROCE | 33.91% |
| Benchmark Median ROCE | 12.62% |
| Company Market Capitalisation | Rs 2,118.6 crore |
| Benchmark Median Market Cap | Rs 142.3 crore |
NGL Fine-Chem Ltd. (NGLFINE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
NGL Fine-Chem Ltd. (NGLFINE) has a P/E ratio of 44.02x, which is above the benchmark median of 18.11x, a difference of +143.07%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
NGL Fine-Chem Ltd. (NGLFINE) has a ROE of 27.9%, which is above the benchmark median of 9.89%, a difference of +182.1%. NGL Fine-Chem Ltd. (NGLFINE) has a ROCE of 33.91%, which is above the benchmark median of 12.62%, a difference of +168.7%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Venus Remedies Ltd. | VENUSREM-BE | 2,068.61 | 17.81 | 3.01 | 9.85 | 7.89 |
| Hester Biosciences Ltd. | HESTERBIO | 2,057.85 | 15.11 | 4.52 | 16.17 | 14.12 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,057.67 | 46.96 | 7.01 | 11.42 | 13.15 |
| Sakar Healthcare Ltd. | SAKAR | 2,057.34 | 56.99 | 6.15 | 11.88 | 13.16 |
| Indoco Remedies Ltd. | INDOCO | 2,045.45 | 363.31 | 2.04 | 12.85 | 15.67 |
NGL Fine-Chem Ltd. (NGLFINE) has a P/E ratio of 44.02x compared with the displayed peer median of 46.96x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.9% compares with a peer median of 11.88% across the companies shown in the table. ROCE stood at 33.91% versus the displayed peer median of 13.16%, providing a capital-efficiency comparison. NGL Fine-Chem Ltd. (NGLFINE) has a market capitalisation of Rs 2,118.6 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching NGL Fine-Chem Ltd.
- NGL Fine-Chem Ltd. Share Price is at Rs 3,487.80 and the stock has been identified by the Univest screener as trading within 2% of its 52-week high.
- The company carries a market capitalisation of Rs 2,118.60 crore, keeping it relevant within the listed Pharmaceuticals & Drugs comparison set.
- Valuation is premium-led, with a P/E of 44.02 and P/B of 6.43, both above same-industry medians.
- Profitability metrics are strong, with ROE of 27.90% and ROCE of 33.91%, both well above benchmark medians.
- Peer comparison shows stronger returns ratios than several similarly sized listed companies in the Healthcare space.
- The same-industry benchmark spans 139 companies, giving the current NGL Fine-Chem Ltd. Share Price setup a meaningful comparative backdrop on Univest.
About NGL Fine-Chem Ltd.
NGL Fine-Chem Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. In market terms, it sits among the larger companies in its same-industry comparison universe, with a market capitalisation of Rs 2,118.60 crore versus an industry median of Rs 142.30 crore and an average of Rs 477.72 crore.
The currently supplied dataset does not extend into product-wise or segment-wise revenue details, but it does establish the company’s listed market position through valuation and profitability markers. NGL Fine-Chem Ltd. Share Price is therefore being assessed here mainly through its industry classification, market size and financial ratios rather than through a business-segment breakdown.
For investors tracking Healthcare and pharmaceutical counters, that still provides useful context. The company stands inside a 139-company same-industry benchmark and a 201-company broader sector universe, while its current valuation and return profile place it above many direct comparables on profitability and above the median on valuation.
Track NGL Fine-Chem Ltd. Share Price on Univest
Use NGL Fine-Chem Ltd. (NGLFINE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers tracking NGL Fine-Chem Ltd. Share Price can use Univest to follow live share price moves, 52-week levels, valuation ratios, profitability metrics, sector comparisons and peer benchmarks in one place. For stocks approaching yearly highs, that combination is useful because it helps separate headline price attention from the underlying numbers.
Univest also allows users to monitor NGL Fine-Chem Ltd. Share Price Today alongside metrics such as P/E, P/B, ROE, ROCE, EPS, book value, dividend yield and broader Healthcare sector comparisons. When a stock is close to its 52-week high, keeping these reference points together can make market context clearer without turning the exercise into a recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is NGL Fine-Chem Ltd. Share Price today?
Ans. NGL Fine-Chem Ltd. Share Price was Rs 3,487.80 at the event qualification time of 10 August 2026 at 10:30:37 AM IST. The same Univest screen also identified the stock as trading within 2% of its 52-week high.
Why is NGL Fine-Chem Ltd. Share Price in focus?
Ans. The stock is in focus because Univest identified NGL Fine-Chem Ltd. Share Price as trading within 2% of its 52-week high. It also carries a market capitalisation of Rs 2,118.60 crore and strong profitability ratios.
What do the valuation ratios say about NGL Fine-Chem Ltd.?
Ans. NGL Fine-Chem Ltd. trades at a P/E of 44.02 and a P/B of 6.43. Those multiples are above the same-industry median values of 18.11 and 1.82, indicating that the stock is priced at a premium.
How profitable is NGL Fine-Chem Ltd. compared with its industry?
Ans. The company reports ROE of 27.90% and ROCE of 33.91%. Both are well above the same-industry medians of 9.89% and 12.62, showing stronger profitability than the typical company in its comparison universe.
What does EPS and book value show for NGL Fine-Chem Ltd.?
Ans. EPS stands at Rs 77.90, which shows earnings attributable to each share, while book value is Rs 532.92 per share. These figures help investors judge NGL Fine-Chem Ltd. Share Price against earnings and accounting net worth.
Does NGL Fine-Chem Ltd. pay a dividend?
Ans. The supplied data shows a dividend yield of 0.05. That indicates a very small payout relative to the current NGL Fine-Chem Ltd. Share Price, so the stock’s current attention is more linked to valuation and profitability.
How does NGL Fine-Chem Ltd. compare with similar listed peers?
Ans. Against peers such as Venus Remedies, Hester Biosciences, Fredun Pharmaceuticals, Sakar Healthcare and Indoco Remedies, NGL Fine-Chem Ltd. has one of the strongest ROE and ROCE profiles, though its valuation multiples remain on the higher side.
Which sector and industry does NGL Fine-Chem Ltd. belong to?
Ans. NGL Fine-Chem Ltd. belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark uses a same-industry scope covering 139 companies, while the broader sector universe includes 201 companies.
